Neratinib 698387-09-6
1 Inquiries
698387-09-6
Pharmaceutical Grade
99%
shenzhen
Flying
1kg
2025-11-15
vitamin
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Neratinib
Other Name:2-Butenamide,N-[4-[[3-chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-,(2E)-;(2E)-N-[4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide;HKI 272;(E)-N-[4-[3-Chloro-4-[(2-pyridinyl)methoxy]anilino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide;Neratinib;(E)-N-[4-[[3-Chloro-4-((pyridin-2-yl)methoxy)phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)-2-butenamide;736156-77-7
CAS No.:698387-09-6
Molecular Formula:C30H29ClN6O3
InChIKeys:InChIKey=JWNPDZNEKVCWMY-VQHVLOKHSA-N
Molecular Weight:557.04266
Exact Mass:557.04
EC Number:1308068-626-2
UNII:JJH94R3PWB
DSSTox ID:DTXSID70220132
NCI Thesaurus Code:C49094
ATC Code:L01EH02|L - Antineoplastic and immunomodulating agents
HScode:29334900
Categories:
Characteristics-
PSA:
112
XLogP3:4.9
Density:1.33
Boiling Point:757°C at 760 mmHg
Flash Point:411.601ºC
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
vitamin
-
Location:
Room 2-502, Building 6, Luneng Tehran Garden Building, No.8 Changbin Road, Xiuying district, Haikou City, Hainan Province
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment
-
Average lead Time:
25
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2023
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
India
Neratinib 99%
10 G Nov 14, 2023 Post an enquiry for this product